Gastrointestinal biomarker tests enhance patient diagnosis of IBD and pancreatic insufficiency on leading clinical chemistry platforms SAN DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation ...
The positions in the table below reflect the BÜHLMANN Laboratories AG's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...
SAN DIEGO, July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo ...
Article ‘Count’ and ‘Share’ for BÜHLMANN Laboratories AG based on listed parameters only. The articles listed below published by authors from BÜHLMANN Laboratories AG, organized by journal and article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results